Skip to Main Content

Author Details

Bonaventura Clotet
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
1979
939
90
Kirsten Obernier (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37984511Vagus nerve dysfunction in the post-COVID-19 condition: a pilot cross-sectional study.Clin Microbiol Infect2024
37667113SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer.Cell Oncol (Dordr)2024
35981912Role of Siglecs in viral infections: A double-edged sword interaction.Mol Aspects Med2023
38023553A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes.Open Forum Infect Dis2023
37954002Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study.Lancet Reg Health Eur2023
37515121Cetylpyridinium Chloride-Containing Mouthwashes Show Virucidal Activity against Herpes Simplex Virus Type 1.Viruses2023
37506557Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination.EBioMedicine2023
37783731Self-sampling monkeypox virus testing in high-risk populations, asymptomatic or with unrecognized Mpox, in Spain.Nat Commun2023
37775521Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2.NPJ Vaccines2023
37723971Selective loss of CD107a TIGIT+ memory HIV-1-specific CD8+ T cells in PLWH over a decade of ART.Elife2023
37090699Syphilis vaccine: challenges, controversies and opportunities.Front Immunol2023
37024469An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses.NPJ Vaccines2023
37457256Corrigendum: Disseminated tuberculosis and diagnosis delay during the COVID-19 era in a Western European country: a case series analysis.Front Public Health2023
37014919Schistosomiasis screening in non-endemic countries from a cost perspective: Knowledge gaps and research priorities. The case of African long-term residents in a Metropolitan Area, Spain.PLoS Negl Trop Dis2023
37240371Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform-Analysis of Production and Immunogenicity.Int J Mol Sci2023
37275492Disseminated tuberculosis and diagnosis delay during the COVID-19 era in a Western European country: a case series analysis.Front Public Health2023
37131861Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial.Lancet Reg Health Eur2023
36999095Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization.iScience2023
37395474Impact of Obefazimod on Viral Persistence, Inflammation, and Immune Activation in People With Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy.J Infect Dis2023
36820900Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines.Cancer Immunol Immunother2023
36782210Identifying the needs of older people living with HIV (⿥⿿50 years old) from multiple centres over the world: a descriptive analysis.AIDS Res Ther2023
36748086Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2.iScience2023
36719240Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction.J Virol2023
36649273Cost-effectiveness analysis of the daily HIV pre-exposure prophylaxis in men who have sex with men in Barcelona.PLoS One2023
36845138SAMHD1 expression modulates innate immune activation and correlates with ovarian cancer prognosis.Front Immunol2023
36806802Author Correction: Modulation of the autophagic pathway inhibits HIV-1 infection in human lymphoid tissue cultured ex vivo.Sci Rep2023
36495129Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS-CoV-2 mRNA-1237 vaccine in patients with solid tumors.Mol Oncol2023
36370091Evaluating the Accuracy of Self-Collected Swabs for the Diagnosis of Mpox.Clin Infect Dis2023
34743624Accentuated aging associated with HIV in a Mediterranean setting occurs mainly in persons aged>70 years: a comparative cohort study (Over50 cohort).AIDS Care2022
35410461Gut microbiome signatures linked to HIV-1 reservoir size and viremia control.Microbiome2022
35470944Prevalence, progression, and management of advanced chronic kidney disease in a cohort of people living with HIV.HIV Med2022
35372213Schistosomiasis Among Female Migrants in Non-endemic Countries: Neglected Among the Neglected? A Pilot Study.Front Public Health2022
35342993Altered T-cell subset distribution in the viral reservoir in HIV-1-infected individuals with extremely low proviral DNA (LoViReTs).J Intern Med2022
35762509Lamivudine, a reverse transcriptase inhibitor, rescues cognitive deficits in a mouse model of down syndrome.J Cell Mol Med2022
35727681Cetylpyridinium Chloride Mouthwash to Reduce Shedding of Infectious SARS-CoV-2: A Double-Blind Randomized Clinical Trial.J Dent Res2022
35602059Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice.Front Microbiol2022
35572570Virological and Clinical Determinants of the Magnitude of Humoral Responses to SARS-CoV-2 in Mild-Symptomatic Individuals.Front Immunol2022
35821254Author Correction to: SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells.Cell Mol Immunol2022
35595256Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilities.Age Ageing2022
35523829Modulation of the autophagic pathway inhibits HIV-1 infection in human lymphoid tissue cultured ex vivo.Sci Rep2022
35814341Re-examining the importance of mask-wearing at mass gathering events-Authors' reply.Lancet Reg Health Eur2022
35620108Performance of SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Tests for Omicron and Other Variants of Concern.Front Microbiol2022
35415002Small form factor flow virometer for SARS-CoV-2.Biomed Opt Express2022
35619701Skewed Cellular Distribution and Low Activation of Functional T-Cell Responses in SARS-CoV-2 Non-Seroconvertors.Front Immunol2022
36619546Factors associated with critical care requirements in diabetic patients treated with dexamethasone for COVID-19 infection in the first wave of the pandemia.Front Endocrinol (Lausanne)2022
36422615Correlation between Clinical and Immunological Variables and Humoral Response to SARS-CoV-2 Vaccination in Adult Patients with Antibody Deficiency Disorders.Pathogens2022
36499329Pharmacological Inhibition of IKK to Tackle Latency and Hyperinflammation in Chronic HIV-1 Infection.Int J Mol Sci2022
36458182Agreement and differential use of laboratory methods for the detection and quantification of SARS-CoV-2 in experimentally infected animals.Front Microbiol2022
36528712Monitoring SARS-CoV-2 variant transitions using differences in diagnostic cycle threshold values of target genes.Sci Rep2022
36146808Susceptibility of Domestic Goat (<i>Capra aegagrus hircus</i>) to Experimental Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) B.1.351/Beta Variant.Viruses2022
  • 1 - 50 of 939

Recommended Authors

Padua University Hospital
Career Start Year 2016
Number of shared co-authors 2
Yale School of Medicine, Yale University
Career Start Year 2014
Number of shared co-authors 1
University of Nebraska Medical Center
Career Start Year 2011
Number of shared co-authors 1
Goethe University Frankfurt, University Hospital
Career Start Year 2003
Number of shared co-authors 5
University of California san francisco
Career Start Year 2002
Number of shared co-authors 9
Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 9
University of California San Diego
Career Start Year 2001
Number of shared co-authors 9
Northwestern University Feinberg School of Medicine
Career Start Year 2000
Number of shared co-authors 10
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 8
The University of North Carolina School of Medicine
Career Start Year 1997
Number of shared co-authors 11
Harvard TH Chan School of Public Health
Career Start Year 1996
Number of shared co-authors 5
Kaiser Permanente San Francisco Medical Center
Career Start Year 1994
Number of shared co-authors 2
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Career Start Year 1993
Number of shared co-authors 11
Johns Hopkins School of Medicine, Johns Hopkins University
Career Start Year 1990
Number of shared co-authors 4
David Geffen School of Medicine, University of California los angeles
Career Start Year 1989
Number of shared co-authors 12
Harvard School of Public Health
Career Start Year 1989
Number of shared co-authors 6
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1988
Number of shared co-authors 18
Vanderbilt University Medical Center
Career Start Year 1988
Number of shared co-authors 17
University of Massachusetts Medical School-Baystate
Career Start Year 1988
Number of shared co-authors 7
University of Cincinnati
Career Start Year 1988
Number of shared co-authors 9
Sacramento Medical Center, Kaiser Permanente Northern California
Career Start Year 1988
Number of shared co-authors 2
VA Medical Center
Career Start Year 1986
Number of shared co-authors 2
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1985
Number of shared co-authors 11
University of Washington
Career Start Year 1984
Number of shared co-authors 7
Vanderbilt University Medical Center
Career Start Year 1983
Number of shared co-authors 0
David Geffen School of Medicine, University of California los angeles
Career Start Year 1982
Number of shared co-authors 2
Case Western Reserve University
Career Start Year 1981
Number of shared co-authors 2
Institute for Global Health Sciences, University of California san francisco
Career Start Year 1977
Number of shared co-authors 11
University of California San Diego
Career Start Year 1975
Number of shared co-authors 3
Johns Hopkins Bloomberg School of Public Health
Career Start Year 1973
Number of shared co-authors 13

Collaborators

Hospital Germans Trias i Pujol
Co-authored papers 110
Co-authored papers 68
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Co-authored papers 46
Co-authored papers 23
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 22
Center for AIDS Research, University of California San Diego
Co-authored papers 21
Campus de la Universitat Autonoma de Barcelona (UAB)
Co-authored papers 19
Co-authored papers 18
The University of Texas MD Anderson Cancer Center
Co-authored papers 18
La Paz University Hospital
Co-authored papers 16
Co-authored papers 16
Vir Biotechnology Inc.
Co-authored papers 13
Co-authored papers 11
Hospital Clinico San Carlos-IdiSSC, Universidad Complutense
Co-authored papers 11
Co-authored papers 10
Co-authored papers 8
Co-authored papers 7
Instituto de Investigacion Hospital 12 de Octubre (imas12)
Co-authored papers 6
Co-authored papers 6
Ragon Institute of Mass General
Co-authored papers 5
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Universite Paris Saclay
Co-authored papers 3
Josep Carreras Leukaemia Research Institute (IJC)
Co-authored papers 3
Departamento de Toxicologia y Farmacologia Preclinica
Co-authored papers 3
Co-authored papers 3
Frederick National Laboratory
Co-authored papers 3
Co-authored papers 3